US 12098155
Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use
granted A61KA61K45/06A61P
Quick answer
US patent 12098155 (Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use) held by SPERO THERAPEUTICS, INC. expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SPERO THERAPEUTICS, INC.
- Grant date
- Tue Sep 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K45/06, A61P, A61P31/04